Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial.

Spence JD, Viscoli CM, Inzucchi SE, Dearborn-Tomazos J, Ford GA, Gorman M, Furie KL, Lovejoy AM, Young LH, Kernan WN; IRIS Investigators.

JAMA Neurol. 2019 May 1;76(5):526-535. doi: 10.1001/jamaneurol.2019.0079. Erratum in: JAMA Neurol. 2019 Mar 18;:.

PMID:
30734043
2.

Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone.

Young LH, Viscoli CM, Schwartz GG, Inzucchi SE, Curtis JP, Gorman MJ, Furie KL, Conwit R, Spatz ES, Lovejoy A, Abbott JD, Jacoby DL, Kolansky DM, Ling FS, Pfau SE, Kernan WN; IRIS Investigators.

Circulation. 2018 Sep 18;138(12):1210-1220. doi: 10.1161/CIRCULATIONAHA.118.034763.

3.

Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).

Yaghi S, Furie KL, Viscoli CM, Kamel H, Gorman M, Dearborn J, Young LH, Inzucchi SE, Lovejoy AM, Kasner SE, Conwit R, Kernan WN; IRIS Trial Investigators.

Circulation. 2018 Jan 30;137(5):455-463. doi: 10.1161/CIRCULATIONAHA.117.030458. Epub 2017 Oct 30.

PMID:
29084736
4.

Effects of pioglitazone on cognitive function in patients with a recent ischaemic stroke or TIA: a report from the IRIS trial.

Furie KL, Viscoli CM, Gorman M, Ford GA, Young LH, Inzucchi SE, Guarino PD, Lovejoy AM, Conwit R, Tanne D, Kernan WN; IRIS Trial Investigators.

J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):21-27. doi: 10.1136/jnnp-2017-316361. Epub 2017 Sep 22.

PMID:
28939682
5.

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.

Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Khodadoust MS, Esfahani MS, Liu CL, Zhou L, Scherer F, Kurtz DM, Say C, Carter JN, Merriott DJ, Dudley JC, Binkley MS, Modlin L, Padda SK, Gensheimer MF, West RB, Shrager JB, Neal JW, Wakelee HA, Loo BW Jr, Alizadeh AA, Diehn M.

Cancer Discov. 2017 Dec;7(12):1394-1403. doi: 10.1158/2159-8290.CD-17-0716. Epub 2017 Sep 24.

6.

mRNA pseudouridylation affects RNA metabolism in the parasite Toxoplasma gondii.

Nakamoto MA, Lovejoy AF, Cygan AM, Boothroyd JC.

RNA. 2017 Dec;23(12):1834-1849. doi: 10.1261/rna.062794.117. Epub 2017 Aug 29.

7.

A novel compound heterozygous form of severe protein C deficiency causing bleeding without purpura fulminans.

Herrick NL, Geddis AE, Lovejoy AE, Kim J, Schiff D, Thornburg CD.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26626. Epub 2017 May 9. No abstract available.

PMID:
28485122
8.

Response to Comment on Inzucchi et al. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease. Diabetes Care 2016;39:1684-1692.

Inzucchi SE, Viscoli CM, Young LH, Furie KL, Gorman M, Lovejoy AM, Dagogo-Jack S, Ismail-Beigi F, Korytkowski MT, Pratley RE, Schwartz GG, Kernan WN; IRIS Trial Investigators.

Diabetes Care. 2017 Apr;40(4):e47-e48. doi: 10.2337/dci16-0048. No abstract available.

9.

Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus.

Young LH, Viscoli CM, Curtis JP, Inzucchi SE, Schwartz GG, Lovejoy AM, Furie KL, Gorman MJ, Conwit R, Abbott JD, Jacoby DL, Kolansky DM, Pfau SE, Ling FS, Kernan WN; IRIS Investigators.

Circulation. 2017 May 16;135(20):1882-1893. doi: 10.1161/CIRCULATIONAHA.116.024863. Epub 2017 Feb 28.

10.

Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial.

Viscoli CM, Inzucchi SE, Young LH, Insogna KL, Conwit R, Furie KL, Gorman M, Kelly MA, Lovejoy AM, Kernan WN; IRIS Trial Investigators.

J Clin Endocrinol Metab. 2017 Mar 1;102(3):914-922. doi: 10.1210/jc.2016-3237.

11.

Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.

Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, Kurtz DM, Stehr H, Scherer F, Karlovich CA, Harding TC, Durkin KA, Otterson GA, Thomas Purcell W, Ross Camidge D, Goldman JW, Sequist LV, Piotrowska Z, Wakelee HA, Neal JW, Alizadeh AA, Diehn M.

Nat Commun. 2016 Nov 14;7:13513. doi: 10.1038/ncomms13513. No abstract available.

12.

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.

Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AF, Esfahani MS, Lovejoy AF, Chabon JJ, Klass DM, Liu CL, Zhou L, Glover C, Visser BC, Poultsides GA, Advani RH, Maeda LS, Gupta NK, Levy R, Ohgami RS, Kunder CA, Diehn M, Alizadeh AA.

Sci Transl Med. 2016 Nov 9;8(364):364ra155.

13.

Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance.

Jeong Y, Hoang NT, Lovejoy A, Stehr H, Newman AM, Gentles AJ, Kong W, Truong D, Martin S, Chaudhuri A, Heiser D, Zhou L, Say C, Carter JN, Hiniker SM, Loo BW Jr, West RB, Beachy P, Alizadeh AA, Diehn M.

Cancer Discov. 2017 Jan;7(1):86-101. doi: 10.1158/2159-8290.CD-16-0127. Epub 2016 Sep 23.

14.

Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease.

Inzucchi SE, Viscoli CM, Young LH, Furie KL, Gorman M, Lovejoy AM, Dagogo-Jack S, Ismail-Beigi F, Korytkowski MT, Pratley RE, Schwartz GG, Kernan WN; IRIS Trial Investigators.

Diabetes Care. 2016 Oct;39(10):1684-92. doi: 10.2337/dc16-0798. Epub 2016 Jul 27.

15.

Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.

Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, Kurtz DM, Stehr H, Scherer F, Karlovich CA, Harding TC, Durkin KA, Otterson GA, Purcell WT, Camidge DR, Goldman JW, Sequist LV, Piotrowska Z, Wakelee HA, Neal JW, Alizadeh AA, Diehn M.

Nat Commun. 2016 Jun 10;7:11815. doi: 10.1038/ncomms11815. Erratum in: Nat Commun. 2016 Nov 14;7:13513.

16.

Integrated digital error suppression for improved detection of circulating tumor DNA.

Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F, Stehr H, Liu CL, Bratman SV, Say C, Zhou L, Carter JN, West RB, Sledge GW, Shrager JB, Loo BW Jr, Neal JW, Wakelee HA, Diehn M, Alizadeh AA.

Nat Biotechnol. 2016 May;34(5):547-555. doi: 10.1038/nbt.3520. Epub 2016 Mar 28.

17.

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.

Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, Guarino PD, Lovejoy AM, Peduzzi PN, Conwit R, Brass LM, Schwartz GG, Adams HP Jr, Berger L, Carolei A, Clark W, Coull B, Ford GA, Kleindorfer D, O'Leary JR, Parsons MW, Ringleb P, Sen S, Spence JD, Tanne D, Wang D, Winder TR; IRIS Trial Investigators.

N Engl J Med. 2016 Apr 7;374(14):1321-31. doi: 10.1056/NEJMoa1506930. Epub 2016 Feb 17.

18.

Corrigendum: Organocatalytic removal of formaldehyde adducts from RNA and DNA bases.

Karmakar S, Harcourt EM, Hewings DS, Scherer F, Lovejoy AF, Kurtz DM, Ehrenschwender T, Barandun LJ, Roost C, Alizadeh AA, Kool ET.

Nat Chem. 2015 Dec;7(12):1033. doi: 10.1038/nchem.2401. No abstract available.

PMID:
26587722
19.

Organocatalytic removal of formaldehyde adducts from RNA and DNA bases.

Karmakar S, Harcourt EM, Hewings DS, Scherer F, Lovejoy AF, Kurtz DM, Ehrenschwender T, Barandun LJ, Roost C, Alizadeh AA, Kool ET.

Nat Chem. 2015 Sep;7(9):752-8. doi: 10.1038/nchem.2307. Epub 2015 Aug 3. Erratum in: Nat Chem. 2015 Dec;7(12):1033.

20.

Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial.

Viscoli CM, Brass LM, Carolei A, Conwit R, Ford GA, Furie KL, Gorman M, Guarino PD, Inzucchi SE, Lovejoy AM, Parsons MW, Peduzzi PN, Ringleb PA, Schwartz GG, Spence JD, Tanne D, Young LH, Kernan WN; IRIS Trial investigators.

Am Heart J. 2014 Dec;168(6):823-9.e6. doi: 10.1016/j.ahj.2014.07.016. Epub 2014 Jul 28.

21.

Transcriptome-wide mapping of pseudouridines: pseudouridine synthases modify specific mRNAs in S. cerevisiae.

Lovejoy AF, Riordan DP, Brown PO.

PLoS One. 2014 Oct 29;9(10):e110799. doi: 10.1371/journal.pone.0110799. eCollection 2014.

22.

Acute prognostic factors for post-thrombotic syndrome in children with limb DVT: a bi-institutional cohort study.

Lyle CA, Gibson E, Lovejoy AE, Goldenberg NA.

Thromb Res. 2013 Jan;131(1):37-41. doi: 10.1016/j.thromres.2012.10.012. Epub 2012 Nov 26.

PMID:
23195142
23.

Beyond borders.

Lovejoy A.

Nurs Womens Health. 2012 Feb-Mar;16(1):9. doi: 10.1111/j.1751-486X.2012.01693. No abstract available.

PMID:
22900720
24.

Boosting enrolment in clinical trials: validation of a regional network model.

Kernan W, Viscoli C, Brass L, Amatangelo M, Birch A, Clark W, Conwit R, Furie K, Gorman M, Pesapane B, Kleindorfer D, Lovejoy A, Osborne J, Silliman S, Zweifler R, Horwitz R.

Clin Trials. 2011 Oct;8(5):645-53. doi: 10.1177/1740774511414925. Epub 2011 Aug 8.

25.

Advocacy: it is what we do.

Stokowski LA, Sansoucie DA, McDonald KQ, Stein J, Robinson C, Lovejoy A.

Adv Neonatal Care. 2010 Apr;10(2):75-82. doi: 10.1097/ANC.0b013e3181d50db8.

PMID:
20386372
26.

A male adolescent with left iliac thrombophlebitis and heterozygosity for factor V Leiden mutation.

Lovejoy AE, Bush RA, Pong AL, Hilfiker ML.

J Pediatr Surg. 2009 Aug;44(8):1640-2. doi: 10.1016/j.jpedsurg.2009.04.013.

PMID:
19635319
27.

Boosting enrollment in neurology trials with Local Identification and Outreach Networks (LIONs).

Kernan WN, Viscoli CM, Demarco D, Mendes B, Shrauger K, Schindler JL, McVeety JC, Sicklick A, Moalli D, Greco P, Bravata DM, Eisen S, Resor L, Sena K, Story D, Brass LM, Furie KL, Gutmann L, Hinnau E, Gorman M, Lovejoy AM, Inzucchi SE, Young LH, Horwitz RI; IRIS Trial Investigators.

Neurology. 2009 Apr 14;72(15):1345-51. doi: 10.1212/WNL.0b013e3181a0fda3.

28.
29.
30.

Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation.

Young G, Yonekawa KE, Nakagawa PA, Blain RC, Lovejoy AE, Nugent DJ.

Blood Coagul Fibrinolysis. 2007 Mar;18(2):97-103.

PMID:
17287624
31.

Preparation of radioiodinated peptide nucleic acids with high specific activity.

Tovar-Salazar A, Dhawan J, Lovejoy A, Liu QA, Gifford AN.

Anal Biochem. 2007 Jan 1;360(1):92-8. Epub 2006 Oct 27.

PMID:
17094934
32.

Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency.

Lovejoy AE, Reynolds TC, Visich JE, Butine MD, Young G, Belvedere MA, Blain RC, Pederson SM, Ishak LM, Nugent DJ.

Blood. 2006 Jul 1;108(1):57-62. Epub 2006 Mar 23.

PMID:
16556896
33.

Prescribing analysis and cost tabulation (PACT) data: an introduction.

Lovejoy AE, Savage I.

Br J Community Nurs. 2001 Feb;6(2):62-7.

PMID:
11927873
34.

DNA polymerases from hyperthermophiles.

Hogrefe HH, Cline J, Lovejoy AE, Nielson KB.

Methods Enzymol. 2001;334:91-116. No abstract available.

PMID:
11398488
35.
36.

A bacteriophage lambda vector for the cloning and expression of immunoglobulin Fab fragments on the surface of filamentous phage.

Hogrefe HH, Mullinax RL, Lovejoy AE, Hay BN, Sorge JA.

Gene. 1993 Jun 15;128(1):119-26.

PMID:
8508952
37.

CONDITIONS AT THE UNIVERSITY OF UTAH.

Dewey J, Lovejoy AO, Seligman ER.

Science. 1915 May 7;41(1062):685. No abstract available.

PMID:
17790161
38.

ORGANIZATION OF THE AMERICAN ASSOCIATION OF UNIVERSITY PROFESSORS.

Lovejoy AO.

Science. 1915 Jan 29;41(1048):151-4. No abstract available.

PMID:
17811572
39.

THE ASSOCIATION OF UNIVERSITY PROFESSORS.

Lovejoy AO.

Science. 1914 Nov 20;40(1038):744-5. No abstract available.

PMID:
17814173
40.

THE METAMORPHOSIS OF THE CARNEGIE FOUNDATION.

Lovejoy AO.

Science. 1913 Apr 11;37(954):546-52. No abstract available.

PMID:
17836331
41.

THE MEANING OF DRIESCH AND THE MEANING OF VITALISM.

Lovejoy AO.

Science. 1912 Nov 15;36(933):672-5. No abstract available.

PMID:
17780093
42.

THE IMPORT OF VITALISM.

Lovejoy AO.

Science. 1911 Jul 21;34(864):75-80. No abstract available.

PMID:
17736908
43.

THE MEANING OF VITALISM.

Lovejoy AO.

Science. 1911 Apr 21;33(851):610-4. No abstract available.

PMID:
17798172
44.

THE RETROSPECTIVE ANTICIPATIONS OF THE CARNEGIE FOUNDATION.

Lovejoy AO.

Science. 1910 Mar 18;31(794):414-5. No abstract available.

PMID:
17732796

Supplemental Content

Loading ...
Support Center